Towards a quantitative management of metastatic prostate cancer using PSMA PET images
J Kendrick - 2023 - research-repository.uwa.edu.au
In this thesis, several important steps were made in laying the foundation for a more
quantitative analysis of PSMA PET images in the management of prostate cancer. Imaging …
quantitative analysis of PSMA PET images in the management of prostate cancer. Imaging …
Standardized PSMA-PET imaging of advanced prostate Cancer
Imaging of advanced prostate cancer is a challenging task, as it requires longitudinal
characterization of disease extent in a standardized way to enable appropriate treatment …
characterization of disease extent in a standardized way to enable appropriate treatment …
The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
Simple Summary Molecular imaging with PSMA PET–CT is more accurate and sensitive
than conventional imaging with CT, MRI, and a Technetium-99 bone scan. This new imaging …
than conventional imaging with CT, MRI, and a Technetium-99 bone scan. This new imaging …
Prognostic value of PSMA PET/CT in prostate cancer
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …
Proposal for systemic-therapy response-assessment criteria at the time of PSMA PET/CT imaging: the PSMA PET progression criteria
In around 20% of men with prostate cancer, metastasis develops during the course of their
disease. Accordingly, discovering and developing new potent treatment strategies for …
disease. Accordingly, discovering and developing new potent treatment strategies for …
Using PSMA imaging for prognostication in localized and advanced prostate cancer
MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …
prostate cancer management has evolved rapidly over the past few years, helping to …
The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
R Seifert, M Eiber, K Herrmann, B Hadaschik… - Clinical and …, 2024 - Springer
Prostate-specific membrane antigen targeting PET is currently the most accurate imaging
method for patients with prostate cancer. It has quickly found its way into the clinical routine …
method for patients with prostate cancer. It has quickly found its way into the clinical routine …
[HTML][HTML] Assessing the heterogeneity of response of [68Ga] Ga-PSMA-11 PET/CT lesions in patients with biochemical recurrence of prostate cancer
Introduction Treatment of men with metastatic prostate cancer can be difficult due to the
heterogeneity of response of lesions.[68 Ga] Ga-PSMA-11 (PSMA) PET/CT assists with …
heterogeneity of response of lesions.[68 Ga] Ga-PSMA-11 (PSMA) PET/CT assists with …
Total and anatomically contextualized quantitative 18F-DCFPyL PET at biochemical recurrence to predict subsequent biochemical progression free survival in …
e17015 Background: PSMA PET has been widely adopted in restaging of prostate cancer at
biochemical recurrence. We assess the clinical utility of quantitative parameters on 18F …
biochemical recurrence. We assess the clinical utility of quantitative parameters on 18F …
The impact of PSMA PET/CT imaging in prostate cancer radiation treatment
E Mena, L Lindenberg, P Choyke - Seminars in nuclear medicine, 2022 - Elsevier
Imaging of prostate cancer is rapidly evolving with the introduction of the novel prostate-
specific membrane antigen (PSMA)-targeted PET imaging tool for managing recurrent …
specific membrane antigen (PSMA)-targeted PET imaging tool for managing recurrent …